EDGAR Filing Documents for 0001193125-24-091869

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-24-091869

Filing Date

2024-04-10

Accepted

2024-04-10 16:03:57

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d662042ddefa14a.htm	DEFA14A	10895
2	GRAPHIC	g662042dsp009.jpg	GRAPHIC	274888
3	GRAPHIC	g662042dsp010.jpg	GRAPHIC	177330
	Complete submission text file	0001193125-24-091869.txt		630923

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306

Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676

Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39244 | Film No.: 24835767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)